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2 
ABSTRACT 
 
In the current study, we aimed at identifying the functional role of transient receptor 
potential vanilloid-3 (TRPV3) ion channel in the regulation of human hair growth. 
Using human organ-cultured hair follicles (HF) and cultures of human outer root 
sheath (ORS) keratinocytes, we provide the first evidence that activation of TRPV3 
inhibits human hair growth. TRPV3 immunoreactivity was confined to epithelial 
compartments of the human HF, mainly to the ORS. In organ culture, TRPV3 
activation by plant-derived (e.g. eugenol, 10-1000 µM) or synthetic (e.g. 2-
aminoethoxydiphenyl borate, 1-300 µM) agonists resulted in a dose-dependent 
inhibition of hair shaft elongation, suppression of proliferation, and induction of 
apoptosis and premature HF regression (catagen). Human ORS keratinocytes also 
expressed functional TRPV3, whose stimulation induced membrane currents, 
elevated intracellular calcium concentration, inhibited proliferation, and induced 
apoptosis. Of great importance, these effects on ORS keratinocytes were all 
mediated by TRPV3 since siRNA-mediated silencing of TRPV3 effectively abrogated 
the cellular actions of the above agonists. These fi dings collectively support the 
concept that TRPV3 signaling is a significant novel player in human hair growth 
control. Therefore, TRPV3 and the related intracellular signaling mechanism might 
function as a promising, novel target for pharmacological manipulations of clinically 
relevant hair growth disorders. 
 
Page 3 of 43 Journal of Investigative Dermatology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
 
3 
INTRODUCTION 
 
Members of the large transient receptor potential (TRP) ion channel family function 
as “polymodal cellular temperature sensor” molecules. Indeed, these channels were 
shown to be involved in sensation of e.g. temperature challenges, chemical irritants, 
osmolarity, taste, pain, itch, etc. (Clapham, 2003; Nilius et al., 2007; Szállási and 
Blumberg, 1999; Caterina and Julius, 2001; Paus et al., 2006a; Bíró et al., 2007). 
 
Emerging results of the past decade, however, have suggested that roles of TRP 
channels are, by no means, restricted to sensory neuron-coupled processes. 
Stimulated not the least by our pioneering studies with TRPV1 (the “capsaicin 
receptor” of the vanilloid subgroup) on glial and mast cells (Bíró et al., 1998a, 1998b), 
it has now become clear that functional TRP channels are also expressed on many 
different non-neuronal cell types. In the skin, TRPV1 was identified on human 
epidermal and hair follicle keratinocytes, sebocytes, mast cells, and dendritic cells 
(Denda et al., 2001; Southall et al., 2003; Bodó et al., 2004). We have also shown 
that TRPV1 activation suppressed in vitro human hair growth, inhibited proliferation of 
epidermal keratinocytes and sebocytes, induced apoptosis of skin cells, and inhibited 
lipid synthesis of sebocytes (Bodó et al., 2005; Tóth et al., 2009b). Finally, we have 
detected a significant delay in hair follicle cycling of TRPV1 KO mice compared to the 
wild-type control (Bíró et al., 2006). These findings have introduced TRPV1 as a 
significant novel player in human (and murine) skin and hair growth control, and 
suggested that TRP channels and their endogenous ligands may represent additional 
players in the neuroendocrine network of the skin (Slominski and Wortsman, 2000). 
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4 
Intriguingly, another thermosensitive TRP channel, i.e. TRPV3, which is abundantly 
expressed in murine keratinocytes (Xu et al., 2002; Smith et al., 2002; Peier et al., 
2002; Moussaieff et al., 2008), was recently also implicated in the regulation of 
murine epidermal and hair growth. It was also shown that a constitutively active, 
“gain-of-function” mutation of the trpv3 gene resulted in a hairless phenotype in mice 
(and rats) (Asakawa et al., 2006; Xiao et al., 2008). Finally, an elegant study (Cheng 
et al., 2010) has recently demonstrated that TRPV3-coupled signaling mechanisms 
are key regulators of epidermal growth factor-induced murine hair morphogenesis 
and skin barrier formation. 
 
Although these interesting data strongly suggested that TRPV3 (similar to TRPV1) 
may play a profound regulatory role in murine hair growth (Steinhoff and Bíró, 2009); 
moreover, although expression of TRPV3 was identified in the human skin in situ (Xu 
et al., 2002; Gopinath et al., 2005; Facer et al., 2007), we lack data on its function in 
human hair growth control. Therefore, in the current study, we aim at defining 
whether TRPV3-coupled signaling is involved in the regulation of human hair growth 
and cycling. Specifically, we intended to identify the expression of TRPV3 in human 
organ-cultured hair follicles (HF) and in primary cultures of HF-derived outer root 
sheath (ORS) keratinocytes using immunolabeling and quantitative “real-time” PCR. 
Furthermore, using a wide-array of functional assays and molecular imaging, we 
have evaluated the effects of plant-derived and synthetic TRPV3 activators on hair 
shaft elongation, intrafollicular and ORS keratinocyte proliferation and apoptosis, HF 
cycling, intracellular ionic homeostasis, and channel activity. Finally, we have 
analyzed the TRPV3-specificity of the observed cellular actions of the TRPV3 
agonists using RNA-interference. 
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Collectively, our study provides the first evidence that activation of TRPV3 inhibits 
human hair growth which findings strongly argue for that TRPV3 and the related 
intracellular signaling mechanism might function as a promising, novel target for 
pharmacological manipulations of clinically relevant hair growth disorders. 
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6 
RESULTS 
 
Human scalp HF express TRPV3 mainly in the ORS 
 
First, we intended to define TRPV3 expression in the human HF in vivo, using full-
thickness normal scalp skin obtained during routine plastic surgery. As revealed by 
immunohistochemistry, TRPV3-immunoreactivity (ir) in human scalp HF in anagen VI 
stage of the hair cycle (Paus and Cotsarelis, 1999; Stenn and Paus, 2001) was 
restricted mostly to the keratinocyte layers of the ORS and, to lesser extent, to the 
matrix of the HF (Figure 1a). In good accord with these data, a strong TRPV3-ir was 
observed on cultured ORS keratinocytes, both by immunocytochemistry (Figure 1b) 
and Western blotting (Figure 1c). The specificity of the immunosignal was assessed 
by numerous positive and negative controls (see also Materials and methods section 
for details). 
 
In order to control whether intraepithelial TRPV3-ir corresponded to the presence of 
TRPV3 transcripts, RNA was rapidly extracted from freshly microdissected proximal 
human anagen HFs and from ORS keratinocyte cultures and then samples were 
subjected to Q-PCR. As shown in Figure 1d, mRNA transcripts for TRPV3 were 
unambiguously identified both in normal human scalp HF and in HF-derived ORS 
keratinocytes suggesting that the human HF epithelium indeed transcribes the 
TRPV3 gene in vivo. 
 
In these experiments, two other important findings have been revealed. First, TRPV3-
ir (Figure 1a) and specific mRNA transcripts (Figure 1d) were absent from the 
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7 
inductive, specialized HF mesenchyme, the fibroblasts of the dermal papilla (DP) as 
well as from human dermal fibroblast (HDF) (Figure 1d) used as feeder layers for the 
ORS keratinocyte cultures. Second, expression of TRPV3 in the ORS and matrix 
keratinocyte layers of the human HF appeared to be not regulated by the cycling 
machinery of the HF since the levels of TRPV3-specific mRNA transcripts (Figure 
1d) and ir (data not show) were essentially the same in anagen and in spontaneously 
transformed catagen HFs. 
 
TRPV3 stimulation inhibits hair shaft elongation and hair matrix keratinocyte 
proliferation, and induces apoptosis-driven premature catagen regression 
 
In order to explore the functional consequences of TRPV3 stimulation in vitro under 
as physiological conditions as possible, microdissected, organ-cultured normal 
anagen VI scalp HF were exposed to various TRPV3 agonists (Xu et al., 2006; 
Chung et al., 2004a). Plant-derived agents such as eugenol (Figure 2), thymol, and 
carvacrol (data not shown) – major components of clove, thyme, and oregano – and 
well as the synthetic agonist 2-APB significantly inhibited hair shaft elongation in a 
time- and dose-dependent manner (Figure 2a). 
 
Hair growth inhibition was further confirmed by the finding that treatment of cultured 
HFs by these activators for 5 days significantly decreased the number of Ki67+ 
keratinocytes in the anagen hair bulb (Figure 2b). Of further importance, the above 
agents significantly increased the number of TUNEL+ keratinocytes in the hair bulb 
after stimulation, suggesting the induction of apoptosis by TRPV3 stimulation (Figure 
2b). 
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Using quantitative histomorphometry of HE-staining section of HF and analyzing such 
staining based on well-defined morphological criteria (Stenn and Paus, 2001; Müller-
Röver et al., 2001), we next assessed the effect of the TRPV3 agonists on HF cycling 
in vitro, namely on the anagen-catagen transition, which is characterized by massive 
up-regulation of keratinocyte apoptosis and down-regulation of keratinocyte 
proliferation in the anagen hair bulb (Stenn and Paus, 2001; Müller-Röver et al., 
2001; Lindner et al., 1997). As shown in Figure 2c, the agonists stimulated the onset 
of catagen transformation of the HF; whereas in the control, most of the HF (>80 %) 
were in the anagen VI phase, after 8 days of treatment with eugenol or 2-APB, 60-
100% of the HF had entered catagen (Figure 2c). It should be noted, however, that 
these TRPV3 agonists were largely capable of inducing only early catagen stages, 
and that we very rarely found that HF regression in vitro had progressed into late 
stages of the catagen transformation after application of these agents. 
 
TRPV3 is expressed as a Ca2+-permeable ion channel on ORS keratinocytes 
 
Although the above data argued for the functional expression of TRPV3 in 
keratinocyte layers of the human HF, to further analyze the functionality of the 
TRPV3 channel, a series dynamic imaging and electrophysiology experiments were 
performed on primary cultures of human ORS keratinocytes which, as we have 
shown above (Figure 1), express TRPV3-specific mRNA transcripts and proteins. 
 
As revealed by FLIPR-based Ca2+-imaging (Tóth et al., 2009b; Marincsák et al., 
2008), TRPV3 agonists markedly increased [Ca2+]ic in a dose-dependent manner 
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9 
(Figure 3a and b). Of further importance, suppression of [Ca2+] of the culturing 
medium (from 1.8 mM to 0.02 mM) or co-application of 10 µM ruthenium red (a non-
selective channel blocker) (Amann and Maggi, 1991) almost fully prevented the 
actions of the TRPV3 agonists to elevate [Ca2+]ic (Figure 3b) suggesting that these 
agents opened a Ca2+-permeable conductance at the surface membrane of the ORS 
keratinocytes. 
 
To further assess this phenomenon, patch-clamp (whole cell configuration) 
experiments were performed. Since membrane currents elicited by square pulses 
activated quickly and showed no time and voltage dependent inactivation (data not 
shown), currents were initiated by ramp protocols (Figure 3c), applied in every 3 sec. 
Control (i.e. vehicle-treated) ORS keratinocytes showed outwardly rectifying currents 
with an average reversal potential of –12.6±1.5 mV (mean±SEM, n=7). Currents 
were measured and normalized to cell membrane capacitance at four different 
potential during the ramp protocol, i.e. at –90, –40, +40 and +90 mV resulting –
9.5±2.5, –3.5±1.0, 6.2±1.0, and 15.9±3.5 pA/pF, respectively (all data are 
mean±SEM values) (Figure 3e). 
 
Of great importance, both inward and outward currents were markedly and 
significantly (p<0.05) increased by 100 µM 2-APB (Figure 3c-f) which effect was 
reversible. In the presence of 2-APB, the currents measured at –90, –40, +40 and 
+90 mV were –31.9±14.2, –13.8±6.4, 17.3±6.1, and 57.7±16.6 pA/pF, respectively 
(mean±SEM, n=7). In average, the TRPV3 activator approximately tripled both 
inward and outward currents at all potentials. (Notably, all other plant-derived TRPV3 
activator exerted similar effects; data not shown). We have also shown that 10 µM 
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10 
ruthenium red markedly (by 62%, measured at +90 mV, n=3) suppressed the 
amplitude of the 2-APB-induced current (data not shown). 
 
Collectively, these data unambiguously argue for that human HF-derived ORS 
keratinocytes indeed express functional TRPV3 which operates as a Ca2+-permeable 
(most probably non-selective cation) channel at the plasma membrane of the cells, 
similar to as had previously been described on various epidermal keratinocyte 
populations (Peier et al., 2002; Cheng et al., 2010; Chung et al., 2004a, 2004b; 
Huang et al., 2008). 
 
TRPV3 stimulation suppresses proliferation of ORS keratinocytes and induces cell 
death 
 
Since TRPV3 stimulation of organ-cultured HFs inhibited hair shaft elongation and 
intrafollicular proliferation and induced apoptosis (Figure 2), we next investigated the 
cellular effects of TRPV3 activation on growth and survival of human ORS 
keratinocytes. In good accord with these data, as revealed by a wide-array of FLIPR-
based functional assays, eugenol and 2-APB suppressed cellular growth of ORS 
keratinocytes in a dose-dependent manner (Figure 4a-c). In addition, the TRPV3 
activators markedly suppressed the mitochondrial membrane potential (Figure 4a-c), 
one of the earliest hallmarks of apoptosis (Green and Reed, 1998; Susin et al., 
1998). Finally, highest concentrations of the agents were also able to significantly 
(p<0.05) increase Sytox Green accumulation (Figure 4a), a sensitive indicator of 
necrosis/cytotoxicity (Tóth et al., 2009b; Dobrosi et al., 2008). 
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11 
Of further importance, the growth-inhibitory and cell death-inducing actions of the 
TRPV3 activators were markedly abrogated by suppression of [Ca2+] of the culturing 
medium (from 1.8 mM to 0.02 mM) or co-application of 10 µM ruthenium red (Figure 
4b and c), further arguing for that these cellular actions are mediated by the opening 
of the surface membrane TRPV3 ion channels and the resulted Ca2+-influx to the 
ORS keratinocytes. 
 
However, several lines of evidence suggest that the above agents may also activate 
other TRP channels (Bíró et al., 2007; Xu et al., 2006). Furthermore, we lack highly 
selective and commercially available TRPV3 inhibitors. Therefore, in order to further 
assess and verify the TRPV3-specificity of the above cellular responses, a series of 
TRPV3-targeted RNAi knock-down experiments were carried out in accordance with 
the techniques developed in our previous studies and which were optimized for 
various cultured human skin cells (Tóth et al., 2009b; Dobrosi et al., 2008; Griger et 
al., 2008). (The evaluation of efficacy of the RNAi knock-down is shown in 
Supplementary Figure 1.) Of greatest importance, in perfect agreement with the 
above data, silencing of TRPV3 counteracted the effects of eugenol and 2-APB to 
suppress growth (Figure 4d) and to stimulate apoptosis (Figure 4e) of ORS 
keratinocytes which data unambiguously verified the specific involvement of TRPV3 
in mediating the cellular actions of these agents. 
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DISCUSSION 
 
Uncovering the as yet ill-characterized functions of various TRP channels in human 
skin biology and pathology is an important, integral part of the ongoing exploration of 
the emerging roles of these molecules in regulatory mechanisms of non-neuronal 
tissues and cells (Clapham, 2003; Nilius et al., 2007; Szállási and Blumberg, 1999; 
Caterina and Julius, 2001; Paus et al., 2006a; Bíró et al., 2007). In this context, we 
provide the first evidence that TRPV3, by suppressing HF keratinocyte proliferation 
and inducing apoptosis-driven catagen regression, inhibits in vitro human hair growth. 
Given that these effects were generated with intact components of a normal human 
mini-organ and under assay conditions that preserve in vivo-like key functions of this 
organ during the test period, our findings are both physiologically and clinically 
relevant. Therefore, our current results, which are perfectly in line with previous data 
obtained on various mouse models (Asakawa et al., 2006; Xiao et al., 2008; Cheng 
et al., 2010; Steinhoff and Bíró, 2009; Imura et al., 2007), introduces TRPV3 as a 
significant novel player in human hair growth and cycling control. 
 
That TRPV3 is functionally expressed in well-defined epithelial cellular compartments 
of the human HF is supported by numerous lines of evidence obtained on primary 
cultures of ORS keratinocytes. Indeed, plant-derived and synthetic TRPV3 activators 
induced membrane currents and elevations of [Ca2+]ic which were effectively 
abrogated by the suppression of [Ca2+]ec or by the co-administration of the 
nonselective TRP channel blocker ruthenium red. Of further importance, cellular 
effects of the TRPV3 activators (i.e. inhibition of proliferation, induction of apoptosis) 
were also inhibited by these manipulations and, of greatest importance, by the RNAi 
Page 13 of 43 Journal of Investigative Dermatology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
 
13 
mediated silencing of TRPV3 expression in these cells. Taken together, these data 
strongly argue for that a “TRPV3 channel opening → Ca2+ influx → growth arrest and 
apoptosis of ORS keratinocytes → hair growth inhibition” signaling pathway operates 
in the human HF. 
 
Previously, the functional expression of TRPV3 was mostly identified on (mouse) 
epidermal keratinocytes. Indeed, TRPV3-specific heat and pharmacological agent-
activated membrane currents and [Ca2+]ic elevations were identified in these cells 
(Peier et al., 2002; Xiao et al., 2008; Cheng et al., 2010, Chung et al., 2004a, 2004b; 
Huang et al., 2008). In addition, stimulation of TRPV3 on keratinocytes induced the 
release of various mediators (e.g. interleukin 1α, prostaglandin E2, ATP) (Xu et al., 
2006; Huang et al., 2008; Mandadi et al., 2009) which, as “intercellular messengers”, 
were shown to activate pain and/or itch sensitive sensory afferents (Huang et al., 
2008; Mandadi et al., 2009). However, these mediators are recognized 
proinflammatory agents in the skin (Bíró et al., 1998b, 2007; Paus and Cotsarelis, 
1999; Stenn and Paus, 2001; Paus et al., 2006b); hence, TRPV3 channels 
expressed on keratinocytes were suggested to play a role in cutaneous inflammation. 
Indeed, transgenic overexpression of a “gain-of-function” mutant of the trpv3 gene in 
epidermal keratinocytes of mice resulted in not only pruritus but severe dermatitis as 
well (Yoshioka et al., 2009). Furthermore, our preliminary data suggest that activation 
of TRPV3 significantly suppresses growth of human epidermal keratinocytes (Bíró et 
al., manuscript in preparation). These intriguing findings, along with our current 
presentation on the role of TRPV3 in human (and mouse) hair growth control, 
underscore the key physiological and pathophysiological significance of TRPV3, its 
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14 
elusive endogenous ligands, and the coupled signaling mechanisms in multiple 
cellular compartments of the skin. 
 
Of further importance, we and others have identified almost identical cutaneous 
regulatory mechanisms with the central involvement of another TRP channel, i.e. 
TRPV1. Indeed, stimulation of TRPV1 was shown to inhibit human (and murine) hair 
growth, promote premature catagen regression of the human HF, suppress 
proliferation and induce apoptosis of human epidermal and ORS keratinocytes, and 
induce the release of pro-inflammatory cytokines from these cells (Southall et al., 
2003; Bodó et al., 2005; Bíró et al., 2006). It appears, therefore, that TRPV3-coupled 
signaling mechanisms (similar to those initiated by the activation of cutaneous 
TRPV1) act as key regulators of human hair growth and cycling and, most probably, 
other key biological processes of the skin. 
 
In various heterologous systems ectopically expressing certain TRPs, the TRPV3 
activator 2-APB was shown to be able to activate TRPV1 (Hu et al., 2004) (and 
possibly other TRP channels as well). However, according to our best knowledge, 
there is no data available on the effect of 2-APB on endogenous TRPV1 expressed 
by cultured human or mouse keratinocytes. Since (1) various agents may exert 
completely different affinities to “naïve” and “expressed” channels; and (2) we have 
previously shown that the activation of TRPV1 by capsaicin on human ORS 
keratinocytes induced TRPV1-specific influx of Ca2+ (Bodó et al., 2005), arguing for 
the functional expression of TRPV1 channels in the surface membrane of the ORS 
keratinocytes; our results that TRPV3 siRNA treatment completely abolished the 
effects of 2-APB suggest that the effects of 2-APB to increase [Ca2+]ic and induce 
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15 
membrane current in ORS keratinocytes is most probably mediated by TRPV3 and 
not by TRPV1. 
 
Collectively, our findings may also have therapeutic implications. Our current 
presentation that stimulation of TRPV3 in the HF inhibits human hair growth suggests 
that (e.g. topically applied) TRPV3 agonists might become exploitable as novel, well-
tolerated agents for the clinical management of unwanted hair growth (hirsutism). 
Likewise, future studies are now warranted to explore whether TRPV3 antagonists 
can be effectively employed in the treatment of various forms of hair loss (effluvium, 
alopecia). Finally, our data also invites one to systemically explore in future studies 
how the pro-inflammatory, pruritogenic, and anti-proliferative TRPV3 signaling in the 
skin can be manipulated in a clinically desired manner by endogenous and 
exogenous ligands in the management of relevant dermatoses such as e.g., 
psoriasis, certain forms of dermatitis, or even skin tumors. Therefore, clinicians who 
apply agents that activate and/or sensitize TRPV3 (e.g. camphor) (Xu et al., 2002; 
Peier et al., 2002) now need to take the above into account. 
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16 
MATERIALS AND METHODS 
 
Materials 
 
Eugenol, carvacrol, thymol, and 2-aminoethoxydiphenyl borate (2-APB) were 
purchased from Sigma-Aldrich (St. Louis, MO). 
 
Isolation and maintenance of HFs 
 
The study was approved by the Institutional Research Ethics Committees and 
adhered to Declaration of Helsinki guidelines. Human anagen VI HFs (n=18–24 per 
group) were isolated from skin obtained from males undergoing hair transplantation 
or females undergoing face-lift surgery as we have described before (Bodó et al., 
2005, 2009; Telek et al., 2007; Ramot et al., 2010). Isolated HFs were maintained in 
Williams’ E medium (Invitrogen, Paisley, UK) supplemented with 2 mM L-glutamine 
(Invitrogen), 10 ng/ml hydrocortisone, 10 µg/ml insulin, and antibiotics (all from 
Sigma-Aldrich). Medium was changed every other day whereas treatment with 
various TRPV3 activators was performed daily. Length measurements were 
performed on individual HFs using a light microscope with an eyepiece measuring 
graticule. 
 
Histology 
 
Cryostat sections (6 µm) of cultured HFs were fixed in acetone, air-dried, and 
processed for histology. Hematoxylin and eosin (HE, Sigma-Aldrich) staining was 
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17 
used for studying HF morphology and hair cycle stage (anagen, catagen) of each HF 
was assessed according to defined morphological criteria (Bodó et al., 2005, 2009; 
Telek et al., 2007; Ramot et al., 2010). 
 
ORS keratinocyte cultures 
 
Anagen HFs were digested using trypsin to obtain ORS keratinocytes (Bodó et al., 
2005; Ramot et al., 2010; Limat and Noser, 1986). Similarly, human dermal 
fibroblasts (HDFs) were obtained from de-epidermized dermis using enzymatic 
digestion. ORS cultures were kept on feeder layer of mitomycin-treated HDFs (Bodó 
et al., 2005; Limat et al., 1989) in a 1:3 mixture of Ham’s F12 and Dulbecco’s 
modified Eagle’s medium (both from Invitrogen) supplemented with 0.1 nM cholera 
toxin, 5 µg/ml insulin, 0.4 µg/ml hydrocortisone, 2.43 µg/ml adenine, 2 nM 
triiodothyronine, 10 ng/ml epidermal growth factor, 1 mM ascorbyl-2-phosphate, and 
antibiotics (all from Sigma-Aldrich). 
 
Immunolabeling of TRPV3 
 
For the detection of TRPV3 on isolated HFs and ORS keratinocytes, we performed 
fluorescent immunolabeling (Bodó et al., 2005, 2009; Telek et al., 2007; Ramot et al., 
2010; Poeggeler et al., 2010). Cryostat HF sections or acetone-fixed ORS 
keratinocytes growing on coverslips were first incubated with primary antibody 
(1:200, overnight) against TRPV3 (Abcam, Cambridge, UK) and then with Alexa 
Fluor 488 dye-conjugated secondary antibody (Invitrogen) according to standard 
procedures. In addition, cultured ORS keratinocytes were identified by cytokeratin 7 
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18 
(CK7) immunolabeling using a mouse monoclonal anti-CK7 antibody (1:100, Novus 
Biologicals, Cambridge, UK) and Alexa Fluor 568 dye-conjugated secondary antibody 
(Invitrogen). Nuclei were counterstained with Vectashield mounting medium 
containing DAPI (Vector Laboratories, Burlingame, CA). Images were acquired with 
an Eclipse E600 fluorescent microscope (Nikon, Tokyo, Japan). As negative controls, 
the appropriate primary antibodies were either omitted from the procedure or were 
preabsorbed with synthetic blocking peptides. In addition, the specificity of TRPV3 
staining was also measured on tissues recognized to be positive for the channel; i.e. 
human epidermal skin sections (Gopinath et al., 2005; Facer et al., 2007) as well as 
normal human epidermal and HaCaT keratinocyte cultures (Sherkheli et al., 2009) 
(data not shown). 
 
Ki-67/TUNEL double labeling 
 
To evaluate apoptotic cells in the HFs in co-localization with a proliferation marker Ki-
67, a Ki-67/TUNEL (terminal deoxynucleotidyl transferase biotin-dUTP nick end 
labeling) double-staining method was employed (Bodó et al., 2005, 2009; Telek et 
al., 2007). Cryostat sections were fixed in formalin/ethanol/acetic acid and labeled 
with a digoxigenin-deoxyUTP (ApopTag Fluorescein In Situ Apoptosis detection kit; 
Millipore, Billerica, MA) in presence of terminal deoxynucleotidyl transferase (TdT), 
followed by incubation with a mouse anti-Ki-67 antiserum (DAKO, Carpinteria, CA). 
TUNEL+ cells were visualized by an anti-digoxigenin FITC-conjugated antibody 
(ApopTag kit), whereas Ki-67 was detected by an Alexa Fluor 568 dye-conjugated 
secondary antibody (Invitrogen). Negative controls were performed by omitting TdT 
and the Ki-67 antibody. The number of cells positive for Ki-67 and TUNEL 
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19 
immunoreactivity was counted per hair bulb and was normalized to the number of 
total (DAPI+) cells. 
 
Quantitative “real-time” PCR (Q-PCR) 
 
Q-PCR was performed on an ABI Prism 7000 sequence detection system (Applied 
Biosystems, Foster City, CA) by using the 5’ nuclease assay as we have previously 
described (Bodó et al., 2005, 2009; Telek et al., 2007; Ramot et al., 2010; Poeggeler 
et al., 2010). Total RNA was isolated using TRIzol reagent (Invitrogen) according to 
manufacturer’s protocol. Three µg of total RNA were then reverse-transcribed into 
cDNA by using 15 U of AMV reverse transcriptase (Promega, Madison, WI) and 
0.025 µg/µl random primers (Promega). PCR amplification was performed by using 
the TaqMan primers and probes (TRPV3, assay ID, Hs00376854_m1) using the 
TaqMan universal PCR master mix protocol (Applied Biosystem). As internal 
controls, transcripts of glycerinaldehyde 3-phosphate dehydrogenase (GAPDH, 
assay ID Hs99999905_m1) and cyclophylin (PPIA, assay ID Hs99999904_m1) were 
determined. 
 
Western blotting 
 
To determine the expression of TRPV3 in different keratinocyte cell types, the 
Western blot technique was applied (Bíró et al., 1998a, 1998b; Bodó et al., 2004, 
2005; Telek et al., 2007). Cell lysates of ORS and HaCaT keratinocytes (the latter 
cells were used as positive controls) (Sherkheli et al., 2009) were subjected to SDS-
PAGE, transferred to BioBond nitrocellulose membranes (Whatman, Maidstone, UK), 
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20 
and then probed with the above anti-TRPV3 antibody (1:500, AbCam). A horseradish 
peroxidase polymer-conjugated anti-rabbit IgG antibody (Envision labeling, DAKO) 
were used as a secondary antibody, and the immunoreactive bands were visualized 
by SuperSignal West Pico Chemiluminescent Substrate-enhanced 
chemiluminescence (Pierce, Rockford, IL) using a Gel Logic 1500 Imaging System 
(Kodak, Tokyo, Japan). Negative control was performed by omitting the primary 
antibody. 
 
Microfluorimetric measurements of [Ca2+]i 
 
ORS keratinocyte cells were seeded in 96-well black-well/clear-bottom plates 
(Greiner Bio-One, Kremsmuenster, Austria) at a density of 20000 cells/well on 
mitomycin treated HDF feeder cells (900 cells/well) in ORS keratinocyte medium, 
supplemented as above, and cultured at 37°C for 24 hrs. The cells were then loaded 
with the cytoplasmic calcium indicator 2 µM Fluo-4 AM (Invitrogen) at 37°C for 30 min 
in Hank’s Balanced Salt Solution (HBSS, Invitrogen) supplemented with 1% bovine 
serum albumin and 2.5 mM probenecid (both from Sigma-Aldrich). The cells were 
washed and finally kept in supplemented HBSS for 30 min at 37°C. The plates were 
then placed into a FlexStation II384 Fluorescence Imaging Plate Reader (FLIPR, 
Molecular Devices, Sunnyvale, CA) and changes in [Ca2+]i (reflected by changes in 
fluorescence; λEX=494 nm, λEM=516 nm) induced by various concentrations of the 
drugs were recorded in each well (during the measurement, cells in a given well were 
exposed to only one given concentration of the agent). Experiments were performed 
in quadruplets and the averaged data (±SEM) were used in the calculations 
(Marincsák et al., 2008; Tóth et al., 2009a). 
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21 
 
Patch-clamp experiments 
 
ORS keratinocytes growing on 1 cm diameter coverslips were placed in a 
temperature controlled perfusion chamber mounted on a stage of an inverted Nikon 
microscope. All experiments were conducted at 37°C. Currents were recorded from 
cells superfused with Tyrode’s solution containing (in mM) NaCl 140, KCl 5.4, CaCl2 
2.5, MgCl2 1.2, HEPES 5, glucose 10, at pH 7.4. 2-APB was added to this 
superfusate from a 1 M stock solution in DMSO reaching a final concentration of 100 
µM. Suction pipettes, fabricated from borosilicate glass, had tip resistances of 2-4 
MW after filling with pipette solution composed of (in mM) K-aspartate 100, KCl 45, 
MgCl2 1, HEPES 5, EGTA 10, K-ATP 3. The pH of this solution was adjusted to 7.2 
with KOH. Membrane currents were recorded with a Multiclamp-700A intracellular 
amplifier (Axon Instruments, Molecular Devices) using the whole cell configuration of 
the patch clamp technique (Hamill et al., 1981). After establishing high (>1 GΩ) 
resistance seal by gentle suction, the cell membrane beneath the tip of the electrode 
was disrupted by further suction and/or by applying 1.5 V electrical pulses for 1 ms. 
Ion currents were normalized to cell capacitance, determined in each cell using short 
hyperpolarizing pulses from –10 mV to –20 mV. Average cell capacitance was 
34.5±2.5 pF whereas the series resistance was typically 5-10 MΩ and left 
uncompensated. Experiments were discarded when the amplitude of the measured 
current was unstable within the initial 5 min of the experiment, or the series 
resistance was high or increased during the measurement. Outputs from the clamp 
amplifier were digitized at 10 kHz using an A/D converter (Digidata-1322A, Axon 
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22 
Instruments) under software control (pClamp 9.0, Axon Instruments) (Gönczi et al., 
2007). 
 
Determination of cellular proliferation 
 
The degree of cellular growth (reflecting number of viable cells) was determined by 
measuring the DNA content of cells using CyQUANT Cell Proliferation Assay Kit 
(Invitrogen). ORS keratinocytes (10000 cells/well) were cultured on mitomycin treated 
HDF feeder cells (900 cells/well) in 96-well black-well/clear-bottom plates (Greiner 
Bio One) in quadruplicates and were treated with various compounds for the time 
indicated. Supernatants were then removed by blotting on paper towels, and the 
plates were subsequently frozen at –70°C. The plates were then thawed at room 
temperature, and 200 µl of CyQUANT dye/cell lysis buffer mixture was added to each 
well. After 5 min incubation, fluorescence was measured at 490 nm excitation and 
520 nm emission wavelengths using FLIPR (Molecular Devices) (Tóth et al., 2009b). 
 
Determination of apoptosis 
 
A decrease in the mitochondrial membrane potential is one of the earliest markers of 
apoptosis (Green and Reed, 1998; Susin et al., 1998). Mitochondrial membrane 
potential of ORS keratinocytes was determined using a MitoProbe DiIC1(5) Assay Kit 
(Invitrogen) using our previously optimized protocols (Tóth et al., 2009b; Dobrosi et 
al., 2008). Cells were cultured and treated as described above. After removal of 
supernatants, cells were incubated for 30 minutes with DilC1(5) working solution and 
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23 
the fluorescence of DilC1(5) was measured at 630 nm excitation and 670 nm 
emission wavelengths using the above FLIPR. 
 
Determination of necrosis 
 
Necrotic cell death was determined by SYTOX Green nucleic acid staining 
(Invitrogen). The dye is able to penetrate only to necrotic cells with ruptured plasma 
membranes, whereas healthy cells with intact surface membranes show negligible 
staining. Cells were cultured and treated as described above. Supernatants were 
then discarded and the cells were incubated with 1 µM SYTOX Green solution. 
Fluorescence of SYTOX Green was measured at 490 nm excitation and 520 nm 
emission wavelengths using a FLIPR (Tóth et al., 2009b; Dobrosi et al., 2008). 
 
RNA interference (RNAi) 
 
ORS keratinocytes were transfected by the Neon Transfection System (Invitrogen) 
using the Neon Kit according to manufacturer's instructions. Briefly, cells were 
harvested by trypsinization, washed and suspended in Resuspension buffer 
(Invitrogen). Two TRPV3-specific Stealth RNAi oligonucleotides (IDs: HSS136316 
and HSS175965, 40 nM, Invitrogen) as well as RNAi Negative Control Duplexes 
(Scrambled RNAi, Invitrogen) were transfected to the cells by electroporation 
(settings: 900 V, 20 ms, two times). Transfected cells were then plated into 35 mm 
Petri dishes for verification and 96 well plates for other assays. The efficacy of 
siRNA-driven knockdown (Supplementary Figure 1.) was daily evaluated by 
Western blot analysis and Ca-imaging for 4 days as we have described before (Tóth 
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24 
et al., 2009b; Dobrosi et al., 2008; Griger et al., 2007). In all cases, the specific RNAi 
probes resulted in >70% suppression of the expression of TRPV3 by day 2 and 
remained suppressed for 2 additional days (data not shown). Hence, experiments 
were performed 2 days after transfection. 
 
Statistical analysis 
 
When applicable, data were analyzed using a two-tailed unpaired t-test (except for 
analyzing the patch-clamp data where Student's t-test for paired data was applied) 
and p<0.05 values were regarded as significant differences. 
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FIGURE LEGENDS 
Figure 1. TRPV3 is expressed in the epithelium of human HF and on cultured ORS 
keratinocytes 
Immunofluorescence (green) of TRPV3 in organ-cultured human HFs in situ (a) and 
on primary cultures of ORS keratinocytes (b). ORS, outer root sheath; DP, dermal 
papilla; MK, matrix keratinocytes. Scale bars, 50 µm (a) and 10 µm (b) ORS 
keratinocytes were identified by cytokeratin 7 (CK7) immunolabeling (red 
fluorescence). Nuclei were counterstained by DAPI (blue fluorescence). Insets: pre-
absorption negative control (NC). (c) TRPV3 protein expression in human ORS and 
epidermal HaCaT keratinocytes, as determined by Western blotting. (d) TRPV3 
mRNA expression in human anagen and catagen HFs, ORS keratinocytes (ORSK), 
DP fibroblasts (DPF), and dermal fibroblasts (HDF), as assessed by quantitative 
“real-time” PCR. Data are expressed as mean±SEM of 3 independent determinations 
performed in triplicate. 
 
Figure 2. In organ-cultured HFs, stimulation of TRPV3 inhibits human hair shaft 
elongation and intrafollicular proliferation, and induces apoptosis and premature 
catagen regression 
(a) Hair shaft elongation curves (18–24 HFs per group, mean±SEM). *p<0.05 when 
compared to control. (b) Co-immunolabeling of proliferating (Ki-67+, red 
fluorescence) and apoptotic (TUNEL+, green fluorescence) cells, along with nuclei 
(DAPI+, blue fluorescence). Statistical analysis of number of Ki-67+ and TUNEL+ 
cells as compared with the number of DAPI+ cells. (c) Quantitative hair cycle 
histomorphometry on hematoxylin-eosin-stained sections. Percentage of HF in 
anagen or catagen state was determined. (b,c) Data are expressed as mean±SEM. 
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36 
*p<0.05 when compared to control. DP, dermal papilla, MK, matrix keratinocytes. 
Scale bars, 50 µm. 
 
Figure 3. TRPV3 is expressed as a Ca2+-permeable ion channel on human ORS 
keratinocytes 
(a) Representative fluorimetric Ca2+-imaging data recorded on Fluo-4 loaded ORS 
keratinocytes. The arrow indicates the application of 100 µM 2-APB and 300 µM 
eugenol in solutions containing normal (1.8 mM) or low (0.02 mM) [Ca2+]. (b) 
Statistical analysis of maximal amplitudes of Ca2+-elevations induced by the TRPV3 
agonists in normal (1.8 mM) or low (0.02 mM) [Ca2+] solutions, or in the presence of 
10 µM ruthenium red (measured in normal [Ca2+] solution). In all cases, mean±SEM 
of multiple determinations (n>3) are presented. For statistical analysis, * marks 
significant (p<0.05) differences compared to the control, whereas # marks significant 
(p<0.05) differences compared to the maximal TRPV3 activator-induced Ca2+-
elevations recorded in normal [Ca2+] solution. (c) Representative IV curves recorded 
with a patch-clamp ramp protocol shown in the inset. (d) A usual time-course of a 
single experiment showing 100 µM 2-APB-induced current values measured at –40 
mV (open symbols) and at +90 mV (filled symbols). (e) Statistical analysis of 
normalized currents to cell membrane capacitance (mean±SEM, n=7) measured at –
40 mV (left side downward), +40 mV (left side upward), –90 mV (right side 
downward) and +90 mV (right side upward) in different conditions. (f) Statistical 
analysis of normalized currents in the presence and after washout of 100 µM 2-APB 
measured at –40 mV (left) and +90 mV (right) (mean±SEM, n=7). (e,f) * marks 
significant (p<0.05) differences compared to the control. 
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37 
Figure 4. Activations of TRPV3 on human ORS keratinocytes suppresses 
proliferation and induces cell death 
(a) ORS keratinocytes were treated with various concentrations of TRPV3 activators 
for 48 hrs medium containing normal (1.8 mM) [Ca2+]. Proliferation was determined 
by a CyQUANT assay, apoptosis was assessed by a DilC1(5) assay reflecting 
(decreasing) mitochondrial membrane potential, and necrosis was determined by a 
Sytox Green assay. (b,c) The above treatment protocols were performed in low (0.02 
mM) [Ca2+] medium or in the presence of 10 µM ruthenium red (in normal [Ca2+] 
medium), and alterations in proliferation (b) and apoptosis (c) were assessed. (a-c) 
Data (mean±SEM) are expressed as a percentage of the mean value (defined as 100 
%) of the vehicle-treated control group. * marks significant (p<0.05) differences 
compared to the (1.8. mM [Ca2+]) vehicle-treated control. (b,c) # marks significant 
(p<0.05) differences compared to the TRPV3 activator-treated group (measured in 
normal [Ca2+] medium). (d,e) Two RNAi probes against TRPV3, as well as scrambled 
RNAi probes, were introduced to ORS keratinocytes. Two days after transfection, 
cells were treated by TRPV3 activators for 48 hrs, and alterations in proliferation (d) 
and apoptosis (e) were assessed. Data (mean±SEM) are expressed as a percentage 
of the mean value (defined as 100%) of the vehicle-treated non-transfected control 
group. For statistical analysis, * marks significant (p<0.05) differences compared to 
the Scrambled RNAi-treated group, whereas # marks significant (p<0.05) differences 
compared to the TRPV3 activator-stimulated Scrambled RNAi-treated group. In all 
cases, three-four additional experiments yielded similar results. 
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1 
SUPPLEMENTARY MATERIAL 
 
SUPPLEMENTARY FIGURE LEGENDS 
Supplementary Figure 1. Evaluation of efficiency of RNAi-mediated knock-down of 
TRPV3 in cultured ORS keratinocytes 
Various RNAi probes against TRPV3 (indicated by numbers), as well as a scrambled 
RNAi probe, were introduced to ORS keratinocytes as described under “Materials 
and methods” (Control, transfection reagent-treated control group). To evaluate the 
efficacy of this intervention, at days 1-4 after transfection, cells were subjected to 
Western blot analysis (molecular evaluation) and Ca2+-imaging (functional 
evaluation). (a) Representative Western blot results measured at day 2 after 
transfection. As a house-keeping molecule, to assess equal loading, expression of β-
actin was also determined. Note that both TRPV3-specific RNAi probes employed 
markedly suppressed the expression of the protein. Two additional experiments 
yielded similar results. (b) Ca2+-imaging data recorded at day 2 after transfection. 
Statistical analysis of maximal amplitudes of Ca2+-elevations induced by the TRPV3 
agonists in various Fluo-4-loaded ORS keratinocyte populations. In all cases, 
mean±SEM of multiple determinations are presented. For statistical analysis, * marks 
significant (p<0.05) differences compared to the maximal TRPV3 activator-induced 
Ca2+-elevations measured on Control (transfection reagent-treated) cultures. Note 
that both 100 µM 2-APB and 300 µM eugenol induced significantly smaller Ca2+-
transients in TRPV3-RNAi transfected cells. 
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